Precision Neuroscience has raised $41.0 million in its latest funding round. The company is developing a brain implant, known as a brain-computer interface (BCI), designed to restore communication and independence for individuals with neurological conditions. This cutting-edge technology aims to empower people with paralysis to control digital devices, such as computers and smartphones, using only their thoughts, thereby opening new possibilities for daily life.
This new capital infusion will significantly accelerate the development and refinement of Precision Neuroscience's BCI technology, particularly as the company continues its human trials. The funds are earmarked to support ongoing research, expand engineering efforts, and scale operational capabilities necessary for bringing its innovative solutions closer to patients. Precision's multidisciplinary team, which includes leading experts in neurosurgery, artificial intelligence, machine learning, and microfabrication, is dedicated to advancing these complex solutions with a focus on safety and efficacy.
With this latest investment, Precision Neuroscience has now secured over $155 million in total funding since its inception in 2021. This substantial backing underscores its position as a well-capitalized entity in the rapidly evolving brain-computer interface sector. The company has already developed and validated its technology, initiating human trials in collaboration with some of the nation’s top hospitals.
Precision Neuroscience remains committed to its mission of transforming breakthrough scientific advancements into tangible, real-world solutions for individuals affected by conditions such as spinal cord injury, stroke, and ALS. This funding round is poised to further enable the company to redefine BCI technology and expand opportunities for enhanced independence and communication worldwide.
